Circulation of 'disaster myths' in Haiti could hinder appropriate disposal of bodiesSeptember 30, 2004Myths about the infectious disease threat posed by dead bodies could lead to insensitive and inappropriate treatment of victims' bodies following the floods in Haiti, and need to be checked, according to a public health researcher who has studied the potential risks at length. Although most of the media coverage of the disaster has been responsible and accurate, there have been some reports which wrongly state that dead bodies can cause epidemics. 'Fear that dead bodies cause epidemics in the surviving population has led to measures such as burial in mass graves without proper identification of the victims', comments Oliver Morgan, a researcher at the London School of Hygiene & Tropical Medicine, whose paper reviewing the scientific literature to assess the infectious disease risks of dead bodies following natural disasters appeared in the Pan American Journal of Public Health recently. 'However, in the current situation in Haiti, the risk that dead bodies pose to the public is extremely small', he adds.
Morgan found that most of the victims usually die from trauma rather then 'epidemic-causing' infections. He says: 'In many natural disasters, the risk of epidemics is used to justify measures such as rapid mass burial. The result is that the victims are often not identified, leaving family members searching for their loved ones'. Unlike the general public, those who are involved in close contact with the dead-such as military personnel, rescue workers, volunteers, and others-may be exposed to chronic infectious hazards, including hepatitis B virus, hepatitis C virus, HIV, enteric pathogens, and tuberculosis. Morgan advises that suitable precautions for these people should include training, use of body bags and disposable gloves, good hygiene practice, and vaccination for hepatitis B and tuberculosis. London School of Hygiene & Tropical Medicine (LSHTM) | |||||||||||||||||||||
|
Related Hepatitis News Articles Early trigger for type-1 diabetes found in mice, Stanford scientists report Scientists at the Stanford University School of Medicine are shedding light on how type-1 diabetes begins. To protect against liver disease, body puts cells 'under arrest' A stable form of cell-cycle arrest known to offer potent protection against cancer also limits liver fibrosis, a condition characterized by an excess of fibrous tissue, according to a new report in the August 22nd Cell, a Cell Press publication. Senescence in liver cells is found by CSHL scientists to help limit acute tissue damage Although post-reproductive life in humans is often associated with decline and a loss of powers, an analogous state in certain cells -- called senescence -- is proving to be one of ironic potency. Scientists at Cold Spring Harbor Laboratory (CSHL) today reported that a particular class of senescent liver cells orchestrates a sequence of events in living mice that can limit fibrosis, a natural response of the liver to acute damage. Trapping white blood cells proves novel strategy against chronic viral infections Seeing disease-fighting white blood cells vanish from the blood usually signals a weakened immune system. But preventing white blood cells' circulation by trapping them in the lymph nodes can help mice get rid of a chronic viral infection, researchers at Yerkes National Primate Research Center and the Emory Vaccine Center have found. Trapping white blood cells proves novel strategy against chronic viral infections Seeing disease-fighting white blood cells vanish from the blood usually signals a weakened immune system. But preventing white blood cells' circulation by trapping them in the lymph nodes can help mice get rid of a chronic viral infection, researchers at Yerkes National Primate Research Center and the Emory Vaccine Center have found. Nano vaccine for hepatitis B shows promise for third world Chronic hepatitis B infects 400 million people worldwide, many of them children. Even with three effective vaccines available, hepatitis B remains a stubborn, unrelenting health problem, especially in Africa and other developing areas. Early treatment is key to combating hepatitis C virus Canadian researchers have shown that patients who receive early treatment for Hepatitis C virus (HCV) within the first months following an infection, develop a rapid poly-functional immune response against HCV similar to when infection is erradicted spontaneously, according to a new study published in the Journal of Virology. International panel updates treatment guidelines for HIV infection An evaluation of recent data has led to an update in the guidelines and recommendations for antiretroviral treatment of adult human immunodeficiency virus (HIV) infection, according to an article in the August 6 issue of JAMA, a theme issue on HIV/AIDS. Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered that the efficacy of imiquimod, a clinically important immune response modifier with potent antiviral and antitumor activity, is dependent on the Opioid Growth Factor (OGF)-OGF receptor (OGFr) axis for its action. Researchers disprove long-standing belief about HIV treatment Researchers at Wake Forest University Baptist Medical Center have disproved a long-standing clinical belief that the hepatitis C virus slows or stunts the immune system's ability to restore itself after HIV patients are treated with a combination of drugs known as the "cocktail." More Hepatitis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||